In this review article, I will briefly summarize the literature reporting BACE1 mechanisms that may account for bidirectional interactions between insulin resistance and Aβ plaque growth in an early or preclinical stage of AD (Figure 1). The gene discussed is INS; the disease is Alzheimer disease.